image
Adaptimmune Therapeutics plc ADAP
Healthcare - Biotechnology - NASDAQ - GB
Watchlist
$ 0.5866
-0.778 %
$ 150 M
Market Cap
-1.63
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 122.05% 31.18% 15.81%
Annual Report FY 10-K 2022-12-31 341.50% -4.66% -1.06%
Annual Report FY 10-K 2021-12-31 55.36% -21.52% -21.62%
Annual Report FY 10-K 2020-12-31 252.76% 5.16% 4.55%
Annual Report FY 10-K 2019-12-31 -98.11% -43.61% -69.70%
Annual Report FY 10-K 2018-12-31 57.28% -36.18% -2.11%
Annual Report FY 10-K 2017-12-31 166.47% 2.01% -10.80%
Annual Report FY 10-K 2016-12-31 32.43% -231.56% -215.58%
Annual Report FY 10-K 2015-06-30 1673.22% -69.96% -60.52%
Annual Report FY 10-K 2014-06-30 0.00% -50.07% -53.69%
Annual Report FY 10-K 2013-06-30 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 458.83% 61.37% 68.29%
Quarterly Report Q2 8-K 2024-06-30 2399.63% 425.03% 252.98%
Quarterly Report Q1 8-K 2024-03-31 -88.07% -4681.76% -2974.70%
Quarterly Report Q4 8-K 2023-12-31 -97.89% -65.24% -98.29%
Quarterly Report Q3 8-K 2023-09-30 4.45% -10.09% -7.67%
Quarterly Report Q2 8-K 2023-06-30 -7.37% 51.96% -2.64%
Quarterly Report Q1 8-K 2023-03-31 1231.50% 102.06% 103.31%
Quarterly Report Q4 8-K 2022-12-31 678.26% 24.73% 36.45%
Quarterly Report Q3 8-K 2022-09-30 482.46% 2.31% -1.92%
Quarterly Report Q2 8-K 2022-06-30 78.93% -13.96% -11.29%
Quarterly Report Q1 8-K 2022-03-31 723.73% -33.11% -31.91%
Quarterly Report Q4 8-K 2021-12-31 -5.66% -6.13% -14.26%
Quarterly Report Q3 8-K 2021-09-30 0.84% -19.67% -17.58%
Quarterly Report Q2 8-K 2021-06-30 516.53% -30.75% -29.94%
Quarterly Report Q1 8-K 2021-03-31 -42.97% -34.07% -27.30%
Quarterly Report Q4 8-K 2020-12-31 106.32% -24.69% -23.58%
Quarterly Report Q3 8-K 2020-09-30 403.38% 9.85% 10.58%
Quarterly Report Q2 8-K 2020-06-30 219.75% 27.28% 14.79%
Quarterly Report Q1 8-K 2020-03-31 0.00% -2.75% 11.92%
Quarterly Report Q4 8-K 2019-12-31 -50.78% 18.82% 5.45%
Quarterly Report Q3 8-K 2019-09-30 -99.42% -749.75% -571.69%
Quarterly Report Q2 8-K 2019-06-30 -98.26% 6.29% -22.94%
Quarterly Report Q1 8-K 2019-03-31 0.00% -30.05% -17.58%
Quarterly Report Q4 8-K 2018-12-31 -65.36% -32.68% -8.10%
Quarterly Report Q3 8-K 2018-09-30 50.05% 697.04% 241.49%
Quarterly Report Q2 8-K 2018-06-30 156.69% -116.89% -21.43%
Quarterly Report Q1 8-K 2018-03-31 186.87% 3.23% -29.34%
Quarterly Report Q4 8-K 2017-12-31 -49.98% -76.87% -102.65%
Quarterly Report Q3 8-K 2017-09-30 1025.21% 95.25% 73.36%
Quarterly Report Q2 8-K 2017-06-30 973.48% 8.51% -4.76%
Quarterly Report Q1 8-K 2017-03-31 -2.09% -39.84% -32.07%
Quarterly Report Q4 8-K 2016-12-31 111.76% 8.02% 19.04%
Quarterly Report Q3 8-K 2016-09-30 -38.68% -1260.54% -80.83%
Quarterly Report Q2 8-K 2016-06-30 -88.21% -31.54% -104.38%
Quarterly Report Q1 8-K 2016-03-31 6.96% -85.89% -200.07%
Quarterly Report Q4 8-K 2015-12-31 77.75% -952.80% -348.82%
Quarterly Report Q3 8-K 2015-09-30 157.00% 58.38% -157.91%
Quarterly Report Q2 8-K 2015-06-30 433.76% -563.08% -756.40%
Quarterly Report Q1 8-K 2015-03-31 822.07% -133.11% -36.72%
Quarterly Report Q4 8-K 2014-12-31 0.00% 38.90% -38.45%
Quarterly Report Q3 8-K 2014-09-30 0.00% -28.28% -40.21%
Quarterly Report Q2 8-K 2014-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2014-03-31 0.00% 0.00% 0.00%
Quarterly Report Q4 8-K 2013-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2013-09-30 0.00% 0.00% 0.00%